Parnell Pharmaceuticals Gives Notice of Annual General Meeting and Explanatory Memorandum
21 juin 2022 09h31 HE
|
Parnell Pharmaceuticals Holdings Ltd
SYDNEY, June 21, 2022 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC: PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Announces Business Results Update
24 mai 2017 16h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., May 24, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell to Report Business Update for the Three Months Ended March 31, 2017 on May 24, 2017
18 mai 2017 23h41 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., May 18, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (OTC:PARNF), a fully integrated pharmaceutical company focused on developing, manufacturing and...
年度股東大會通知及說明備忘錄
01 mai 2017 02h01 HE
|
Parnell Pharmaceuticals Holdings Ltd
澳洲悉尼, May 01, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd （場外交易代碼：PARNF），是一家完全整合的商業級製藥公司，致力開發、製造和經銷創新的動物保健醫藥。其年度股東大會將於 2017 年 5 月 29 日，星期一下午4:00（美國中部標準時間）、 2017 年 5 月 30...
Notice of Annual General Meeting and Explanatory Memorandum
28 avr. 2017 02h09 HE
|
Parnell Pharmaceuticals Holdings Ltd
SYDNEY, Australia, April 28, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell Pharmaceuticals Holdings Ltd Announces Financial Results for the Year Ended December 31, 2016
21 mars 2017 16h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., March 21, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (OTC:PARNF), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
UPDATED: Parnell to Report Financial Results for Fiscal Year 2016 on March 21, 2017
27 févr. 2017 13h54 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 27, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (OTC:PARNF), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell to Report Financial Results for Fiscal Year 2016 on March 22, 2017
23 févr. 2017 17h30 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Feb. 23, 2017 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd. (OTC:PARNF), a fully integrated pharmaceutical company focused on developing, manufacturing and...
Parnell Pharmaceuticals Holdings Ltd Files Form 25, Voluntarily Delisting Its Shares From NASDAQ
19 déc. 2016 16h30 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 19, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...
Parnell Pharmaceuticals Holdings Ltd Announces Intention To Move From the NASDAQ OMX Global Market and Expects To Move To the OTC Pink® Open Market
09 déc. 2016 17h00 HE
|
Parnell Pharmaceuticals Holdings Ltd
OVERLAND PARK, Kan., Dec. 09, 2016 (GLOBE NEWSWIRE) -- Parnell Pharmaceuticals Holdings Ltd (NASDAQ:PARN), a fully integrated, commercial-stage pharmaceutical company focused on developing,...